Seventh Circuit urged to review AbbVie antitrust ruling
15-10-2020
AbbVie and Besins to pay FTC $448m in sham litigation case
02-07-2018
FTC secures partial win against AbbVie
18-09-2017
Piotr Swat / Shutterstock.com
A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission (FTC).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
FTC, AbbVie, antitrust, US District Court for the Eastern District of Pennsylvania, Besins healthcare, monopoly, FDA, reverse payment, lawsuit, en banc
